NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Aker Biomarine AS (OL: AKBM)

 
AKBM Technical Analysis
5
As on 9th Jun 2023 AKBM STOCK Price closed @ 33.20 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 48.48 & Strong Sell for SHORT-TERM with Stoploss of 49.13 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

AKBMSTOCK Price

Open 33.30 Change Price %
High 34.50 1 Day -0.05 -0.15
Low 31.50 1 Week -2.00 -5.68
Close 33.20 1 Month -5.35 -13.88
Volume 229486 1 Year -18.00 -35.16
52 Week High 59.00 | 52 Week Low 33.60
 
OL Norway Most Active Stocks
PGS 6.97 -3.19%
NANOV 2.23 -20.64%
AOW 2.00 -5.21%
IDEX 0.71 0.00%
ENSU 0.12 0.00%
SCANA 1.99 2.05%
EQNR 313.65 1.98%
ACH 3.90 2.36%
ARCH 0.91 -1.09%
NAS 12.12 0.83%
 
OL Norway Top Gainers Stocks
INSR 0.18 12.50%
NORSE 21.90 11.17%
MGN 30.50 9.71%
KOMP 5.22 9.66%
PSE 4.03 8.92%
PSE 4.03 8.92%
PSE 4.03 8.92%
PSE 4.03 8.92%
PSE 4.03 8.92%
PSE 4.03 8.92%
 
OL Norway Top Losers Stocks
NANOV 2.23 -20.64%
ABT 5.00 -13.49%
ABT 5.00 -13.49%
ABT 5.00 -13.49%
ABT 5.00 -13.49%
ABT 5.00 -13.49%
ABT 5.00 -13.49%
HYPRO 30.05 -6.09%
HDLY 1.60 -5.88%
AGAS 84.10 -5.29%
 
 
AKBM
Daily Charts
AKBM
Intraday Charts
Whats New @
Bazaartrend
AKBM
Free Analysis
 
AKBM Important Levels Intraday
RESISTANCE38.98
RESISTANCE37.13
RESISTANCE35.98
RESISTANCE34.84
SUPPORT31.57
SUPPORT30.42
SUPPORT29.27
SUPPORT27.42
 
AKBM Forecast April 2024
4th UP Forecast55.75
3rd UP Forecast48.52
2nd UP Forecast44.05
1st UP Forecast39.58
1st DOWN Forecast26.82
2nd DOWN Forecast22.35
3rd DOWN Forecast17.88
4th DOWN Forecast10.65
 
AKBM Weekly Forecast
4th UP Forecast43.03
3rd UP Forecast39.88
2nd UP Forecast37.93
1st UP Forecast35.98
1st DOWN Forecast30.42
2nd DOWN Forecast28.47
3rd DOWN Forecast26.52
4th DOWN Forecast23.37
 
AKBM Forecast2024
4th UP Forecast87.93
3rd UP Forecast70.38
2nd UP Forecast59.53
1st UP Forecast48.68
1st DOWN Forecast17.72
2nd DOWN Forecast6.87
3rd DOWN Forecast-3.98
4th DOWN Forecast-21.53
 
 
AKBM Other Details
Segment EQ
Market Capital 3936995072.00
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Offical website >
 
AKBM Address
AKBM
 
AKBM Latest News
 
Your Comments and Response on Aker Biomarine AS
 
AKBM Business Profile
Aker BioMarine AS develops, produces, and sells krill-derived ingredients for nutraceutical, dietary supplement, and animal feed applications in Norway, the Americas, the Asia Pacific, Europe, the Middle East, and Africa. It operates in two segments, Ingredients and Brands. The company provides krill oil products, including omega-3s, phospholipids, choline, and astaxanthin under the Superba, Kori, NKO, and K·REAL brands. It also offers Qrill aqua nutrient-rich feed ingredients for aquaculture; and QRILL pet, a functional ingredient for pet food. The company also offers LYSOVETA, a delivery platform based on LPC-bound EPA and DHA from krill; and INVI, a hydrolyzed protein isolate for food and beverage applications. In addition, it distributes human health and nutrition products, and natural supplements, as well as provides AION, a circular solution provider that recycles waste into products, such as shopping baskets and food trays. Aker BioMarine AS has an agreement with Medical Food Solutions Research to develop pharmaceutical therapies for brain and eye health based on Lysoveta. The company is headquartered in Lysaker, Norway. Aker BioMarine ASA is a subsidiary of Aker ASA. Address: Oksenøyveien 10, Lysaker, Norway, 1327
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service